News Daily News When Nudges Aren’t Enough: Study Ponders AS Referral System Changes L.A. McKeown February 13, 2026
News Daily News TAVI Patients Seem to Pay No Penalty for Obstructive CAD Yael L. Maxwell December 09, 2025
News Daily News Rising HF Burden in the US Potentially Related to Changes in Cardiometabolic Factors Yael L. Maxwell December 02, 2025
News Daily News Frail Patients Stand to Gain Most From Cardiac Rehab Michael O'Riordan November 26, 2025
News Daily News Mortality and Other Adverse Events After TAVI Higher in Frailer Patients Yael L. Maxwell November 25, 2025
News Daily News Revascularization Decisions in the Elderly Require a Holistic Approach: AHA Caitlin E. Cox November 24, 2025
News Daily News Elderly CABG Patients Stand to Benefit From Artery-Only Strategy Caitlin E. Cox October 13, 2025
News Daily News Type 2 MI Diagnoses on the Rise, but Best Course of Action Unknown Caitlin E. Cox October 08, 2025
News Daily News TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients Caitlin E. Cox August 13, 2025
News Daily News Frail Older Patients With AF May Fare Better Switching to DOAC Todd Neale August 05, 2025
News Daily News POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies L.A. McKeown July 15, 2025
News Daily News Trade-offs With Invasive Strategy in Older Patients With ACS: Meta-analysis Michael O'Riordan July 03, 2025
News Daily News Greater Frailty Means More Complications, Higher Mortality After PCI Todd Neale June 16, 2025
News Daily News Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding L.A. McKeown May 16, 2025
News Daily News Can’t Exercise for a Cardiac Stress Test? That’s a Bad Sign Todd Neale February 25, 2025
News Daily News ELASTA-Clip Plus TMVR Safe, Feasible for Failed M-TEER Caitlin E. Cox February 14, 2025
News Daily News Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab Michael O'Riordan February 05, 2025
News Daily News Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study Michael O'Riordan January 22, 2025